YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib

Author:

Garmendia Irati12ORCID,Pajares María J.1234ORCID,Hermida-Prado Francisco35,Ajona Daniel1634,Bértolo Cristina13,Sainz Cristina1,Lavín Amaya1,Remírez Ana B.1,Valencia Karmele163,Moreno Haritz1,Ferrer Irene37,Behrens Carmen89,Cuadrado Myriam310,Paz-Ares Luis371112,Bustelo Xosé R.310,Gil-Bazo Ignacio3413,Alameda Daniel1,Lecanda Fernando1234,Calvo Alfonso1234,Felip Enriqueta14,Sánchez-Céspedes Montse15,Wistuba Ignacio I.89,Granda-Diaz Rocio35,Rodrigo Juan Pablo35,García-Pedrero Juana María35,Pio Ruben1634,Montuenga Luis M.1234ORCID,Agorreta Jackeline1234

Affiliation:

1. Program in Solid Tumors, Center for Applied Medical Research, Pamplona, Spain

2. Department of Pathology, Anatomy, and Physiology, School of Medicine and

3. Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain

4. Navarra Health Research Institute, Pamplona, Spain

5. Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain

6. Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain

7. Lung Cancer Clinical Research Unit and Centro Nacional de Investigaciones Oncológicas, Madrid, Spain

8. Department of Translational Molecular Pathology and

9. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

10. Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas, University of Salamanca, Salamanca, Spain

11. Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain

12. Medical School, Universidad Complutense, Madrid, Spain

13. Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain

14. Oncology Department, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Barcelona, Spain; and

15. Cancer Epigenetics and Biology Program, Genes and Cancer Group, Bellvitge Biomedical Research Institute, Hospitalet de Llobregat, Barcelona, Spain

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3